Psoriatic arthritis

Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial

Xenofon Baraliakos, Laure Gossec, Effie Pournara, Slawomir Jeka, Antonio Mera-Varela, Salvatore D'Angelo, Barbara Schulz, Michael Rissler, Kriti Nagar, Chiara Perella, Laura C Coates

10.1136/annrheumdis-2020-218808

December 17, 2020

Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2

Philip J Mease, Apinya Lertratanakul, Jaclyn K Anderson, Kim Papp, Filip Van den Bosch, Shigeyoshi Tsuji, Eva Dokoupilova, Mauro Keiserman, Xin Wang, Sheng Zhong, Reva M McCaskill, Patrick Zueger, Aileen L Pangan, William Tillett

10.1136/annrheumdis-2020-218870

December 3, 2020

IL-23 skin and joint profiling in psoriatic arthritis: novel perspectives in understanding clinical responses to IL-23 inhibitors

Alessandra Nerviani, Marie-Astrid Boutet, Wang Sin Gina Tan, Katriona Goldmann, Nirupam Purkayastha, Tamas Ajtos Lajtos, Rebecca Hands, Myles Lewis, Stephen Kelly, Costantino Pitzalis

10.1136/annrheumdis-2020-218186

November 26, 2020

Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials

Philip J Mease, Philip S Helliwell, Kasper Fjellhaugen Hjuler, Kyle Raymond, Iain McInnes

10.1136/annrheumdis-2019-216835

October 26, 2020

DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study

Steven Ho Man Lam, Isaac T Cheng, Edmund K Li, Priscilla Wong, Jolie Lee, Ronald Man-Lung Yip, Cheuk-Wan Yim, Shirley K Ying, Martin Li, Tena K Li, Alex Pui-Wai Lee, Lai-Shan Tam

10.1136/annrheumdis-2020-217595

July 31, 2020

Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study

Jiangwei Xia, Shu-Yang Xie, Ke-Qi Liu, Lin Xu, Pian-Pian Zhao, Si-Rui Gai, Peng-Lin Guan, Jin-Qiu Zhao, Yan-Ping Zhu, Lam C Tsoi, Philip E Stuart, Rajan P Nair, Han-Qi Yang, Yu-Ting Liao, Kaijing Mao, Mo-Chang Qiu, Zhi-Min Ying, Bin Hu, Zhi-Hua Yang, Wei-Yang Bai, Xiao-Wei Zhu, Pei-Kuan Cong, James T Elder, Zhao-Ming Ye, Bin Wang, Hou-Feng Zheng

10.1136/annrheumdis-2020-217892

July 31, 2020

Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52

Josef S Smolen, Philip Mease, Hasan Tahir, Hendrik Schulze-Koops, Inmaculada de la Torre, Lingnan Li, Maja Hojnik, Christophe Sapin, Masato Okada, Roberto Caporali, Jordi Gratacós, Philippe Goupille, Soyi Liu Leage, Sreekumar Pillai, Peter Nash

10.1136/annrheumdis-2020-217372

July 13, 2020

Novel and reliable DACTylitis glObal Sonographic (DACTOS) score in psoriatic arthritis

Alen Zabotti, Garifallia Sakellariou, Ilaria Tinazzi, Luca Idolazzi, Alberto Batticciotto, Marco Canzoni, Greta Carrara, Orazio De Lucia, Fabiana Figus, Nicolò Girolimetto, Pierluigi Macchioni, Rebecca McConnell, Niccolò Possemato, Annamaria Iagnocco

10.1136/annrheumdis-2020-217191

May 19, 2020

Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritis

Emma Dures, Julie Taylor, Sasha Shepperd, Sandeep Mukherjee, Joanna Robson, Ivo Vlaev, Nicola Walsh, Laura C Coates

10.1136/annrheumdis-2020-217301

May 18, 2020

Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression

Abdulla Watad, Hannah Rowe, Tobias Russell, Qiao Zhou, Lisa K Anderson, Almas Khan, Robert Dunsmuir, Peter Loughenbury, Vishal Borse, Abhay Rao, Peter A Millner, Nicola Luigi Bragazzi, Howard Amital, Richard Cuhtbert, Miriam Wittmann, Kassem Sharif, Tony Kenna, Matthew A Brown, Darren Newton, Charlie Bridgewood, Dennis G McGonagle

10.1136/annrheumdis-2020-217309

May 13, 2020